Vycor Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
April 13, 2022 at 01:47 pm EDT
Share
Vycor Medical, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was USD 1.39 million compared to USD 1.14 million a year ago. Net loss was USD 0.435662 million compared to USD 0.822482 million a year ago. Basic loss per share was USD 0.03 compared to USD 0.04 a year ago.
Vycor Medical, Inc. provides surgical and therapeutic solutions. The Company designs, develops and markets neurological medical devices and therapies. The Company operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment designs, develops and markets medical devices for use in neurosurgery. The NovaVision segment provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage such as that caused by a stroke. Vycor Medical's product Vycor Medical's ViewSite Brain Access System (VBAS) is a next generation retraction and access system. Vycor Medical focuses on brain and cervical surgical access systems for sale to hospitals and medical professionals. NovaVision's products include Vision Restoration Therapy (VRT), NeuroEyeCoach and Neuro-Eye Therapy (NeEt). The Company operates in the United States and Europe.
VYCOR MEDICAL, INC. 
